Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
At close: Oct 23, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $6.3 million as of October 23, 2026. It is the 43,849th most valuable company in the world and the 5,851st biggest in the United States. Its market cap has decreased by 54.34% in one year.
Market Cap
6.30M
Enterprise Value
12.12M
Revenue
n/a
Global Rank
Country Rank
#5,851 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 6.30M, a decrease of -94.66%. That is a compound annual growth rate of -9.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 6.30M | 53.64% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 8.48M |
| Oncotelic Therapeutics | 8.42M |
| Zeo ScientifiX | 7.18M |
| OSR Health | 6.88M |
| VitaSpring Biomedical | 6.58M |
| LianMedical | 6.49M |
| TRON Group | 6.11M |
| Reviva Pharmaceuticals Holdings | 5.82M |